DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK

DIFFERENCES IN OUTCOMES IN NEUROMYELITIS OPTICA BETWEEN A JAPANESE COHORT AND A PREDOMINANTLY CAUCASIAN COHORT FROM THE UK

Bibliographic Details
Main Authors:	Kitley, J, Leite, M, Waters, P, McNeillis, B, Brown, R, Takai, Y, Jacob, A, Boggild, M, Nakashima, I, Vincent, A, Palace, J
Format:	Conference item
Published:	2012

Similar Items

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
by: Elsone, L, et al.
Published: (2012)

Prognostic factors in aquaporin-4 antibody-mediated disease: UK and Japanese cohorts
by: Kitley, J, et al.
Published: (2011)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
by: Kitley, J, et al.
Published: (2012)

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
by: Kitley, J, et al.
Published: (2012)

Use of mitoxantrone in neuromyelitis optica.
by: Kitley, J, et al.
Published: (2011)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
by: Elsone, L, et al.
Published: (2013)

Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort
by: Leonard, H, et al.
Published: (2012)

Neuromyelitis optica
by: Jacob Anu, et al.
Published: (2007-01-01)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
by: Elsone, L, et al.
Published: (2014)

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
by: Elsone, L, et al.
Published: (2013)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
by: Kim, W, et al.
Published: (2012)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
by: Kitley, J, et al.
Published: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
by: Kitley, J, et al.
Published: (2014)

NEUROMYELITIS OPTICA SPECTRUM AND RELATIONSHIP WITH AQUAPORIN-4 ANTIBODY DISEASE: THE OXFORD COHORT
by: Leite, M, et al.
Published: (2009)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
by: Kitley, J, et al.
Published: (2012)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Waters, P, et al.
Published: (2015)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
by: Kitley, J, et al.
Published: (2014)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
by: Kitley, J, et al.
Published: (2012)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
by: Kitley, J, et al.
Published: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
by: Kitley, J, et al.
Published: (2013)

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND
by: Luppe, S, et al.
Published: (2012)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
by: Kitley, J, et al.
Published: (2013)

Seasonal pattern of variation in neuromyelitis optica relapses
by: Elsone, L, et al.
Published: (2012)

PREGNANCY OUTCOME IN AQUAPORIN-4 POSITIVE NEUROMYELITIS OPTICA SPECTRUM DISORDER: A MULTI-CENTER RETROSPECTIVE COHORT STUDY
by: Nour, M, et al.
Published: (2014)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
by: Littleton, E, et al.
Published: (2006)

LONG TERM OUTCOME IN NEUROMYELITIS OPTICA: LESSONS FROM 6 YEARS OF THE UK NMO STUDY
by: Jacob, A, et al.
Published: (2009)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
by: Nour, M, et al.
Published: (2014)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
by: Kitley, J, et al.
Published: (2013)

A practical guide to the treatment of neuromyelitis optica.
by: Palace, J, et al.
Published: (2012)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
by: Absoud, M, et al.
Published: (2014)

LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE
by: Kitley, J, et al.
Published: (2012)

A clinical/immunological neuromyelitis optica association study
by: Kitley, J, et al.
Published: (2014)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
by: Jacob, A, et al.
Published: (2012)

AQUAPORIN 4 ANTIBODY SEROPOSITIVITY AND VISUAL FUNCTION IN A UK COHORT
by: George, J, et al.
Published: (2012)

Aquaporin 4 antibody seropositivity and visual function in a UK cohort
by: George, J, et al.
Published: (2011)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
by: Kitley, J, et al.
Published: (2011)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013)

The borderland of neuromyelitis optica.
by: Matthews, L, et al.
Published: (2009)

Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
by: Nour, M, et al.
Published: (2015)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
by: Sato, D, et al.
Published: (2014)